Optum Ventures co-led a series B round that took the chronic disease management platform's total funding to $50m.

Kaia Health, the US-based developer of an online platform for chronic disease management, has completed a $26m series B round co-led by healthcare services provider Optum. Optum’s corporate venturing unit, Optum Ventures, co-led the round with Idinvest and Capital300, while Balderton Capital, Symphony Ventures and Heartcore Capital also participated. The company said the round increased…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.